Marvin E. Rosenthale

Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA.

Allergan Ligand Retinoid Therapeutics, Inc. discovers and develops pharmaceuticals and drugs based on retinoids. Retinoids have biological actions and evidence suggests that retinoids are useful in the treatment of skin diseases, metabolic diseases, cancer including kidney cancer, certain forms of leukemia, other cancers and eye diseases. Allergan Ligand Retinoid Therapeutics was founded in 1994 and is headquartered in Irvine, CA.

NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA.

Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA.

Radient Pharmaceuticals Corp. was engaged in the research, development, manufacturing, sale and marketing of its Onko-Sure test kit, a proprietary in-vitro diagnostic cancer test. The company was founded in 1987 and was headquartered in Tustin, CA.

Part of AbbVie, Inc., Allergan Specialty Therapeutics, Inc. is a company that develops pharmaceutical products based on retinoid and neuroprotective technologies. The company is based in Irvine, CA. Allergan Specialty Therapeutics was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 23, 2001 for $71.02 million.